IP Library › Granted Patent US 12,605,545
Granted Patent B2
US 12,605,545 · App. 18/456,306 · Granted Apr 21, 2026

Template based artifact reduction in neuromodulation applications

Inventors: Andrew Haddock (Los Angeles, CA); Sandeep Avvaru (Houston, TX)
Assignee: Boston Scientific Neuromodulation Corporation
A61N1/36062A61B5/388A61B5/4836A61N1/36139A61N1/36153A61N1/37247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,605,545
App. No.
18/456,306
Granted
Apr 21, 2026
Kind
B2
Abstract

Methods and systems for recording evoked potentials evoked during electrical stimulation of a patient's neural tissue are disclosed. The methods and systems are useful with treatment modalities, such as spinal cord stimulation (SCS). The disclosed methods and system allow for stimulation artifacts to be reduced in, or removed from, the recorded signals. A residual portion of the stimulation artifact can be modeled and subtracted from a recorded signal that includes both artifact and neural response contributions.

Claims (63)

1 . A system for providing electrical stimulation to a patient's spinal cord using one or more electrode leads implantable in the patient's spinal column, each electrode lead comprising a plurality of spinal electrode contacts, the system comprising:

a neurostimulator that is connectable to the one or more electrode leads, and control circuitry configured to:

cause the neurostimulator to use one or more of the spinal electrode contacts to provide a first electrical stimulation to the patient's spinal cord, wherein the first electrical stimulation is configured to evoke a first stimulation artifact but not to evoke a detectable neural response in the patient's spinal cord,

cause the neurostimulator to use a second one or more of the spinal electrode contacts to record a first signal comprising a first stimulation artifact component,

fit the first signal to a mathematical model to yield a template signal, wherein the mathematical model comprises an exponential decay,

cause the neurostimulator to use one or more of the spinal electrode contacts to provide second electrical stimulation to the patient's spinal cord, wherein the second electrical stimulation is configured to evoke a second stimulation artifact and a neural response in the patient's spinal cord,

cause the neurostimulator to use a one or more of the spinal electrode contacts to record a second signal comprising a second stimulation artifact component and a neural response component,

use the second signal and the template signal to determine a third signal, wherein the third signal comprises the neural response component and comprises a smaller stimulation artifact component than does the second signal,

determine one or more features of the third signal, and

use the one or more features of the third signal for closed loop feedback adjustment of therapeutic stimulation.

2 . The system of claim 1 , wherein the amplitude of the first electrical stimulation is less than the amplitude of the second electrical stimulation.

3 . The system of claim 1 , wherein using the second signal and the template to determine a third signal comprises scaling the template signal with respect to the second signal.

4 . The system of claim 3 , wherein using the second signal and the template to determine a third signal comprises subtracting the scaled template signal from the second signal to yield the third signal.

5 . The system of claim 1 , wherein the control circuitry is control circuitry of the neurostimulator.

6 . The system of claim 1 , wherein the control circuitry is control circuitry of an external computing device.

7 . The system of claim 6 , wherein the control circuitry is further configured to display a representation of the third signal on a graphical display of the external computing device.

8 . The system of claim 1 , wherein the therapeutic stimulation is the second electrical stimulation.

9 . The system of claim 1 , wherein the closed loop feedback adjustment is configured to maintain the therapeutic stimulation within a therapeutic window.

10 . The system of claim 1 , wherein the mathematical model comprises a term of the form

V

⁡

(

t

)

=

V

0

⁢

e

-

t

τ

,

where V(t) is voltage as a function of time t, V 0 is peak voltage, and τ is a decay time constant.

11 . The system of claim 10 , wherein the decay time constant t depends on the resistance R and capacitance C of tissue near the electrode contacts.

12 . The system of claim 1 , wherein the neural response is a compound evoked action potential (ECAP).

13 . A method for providing electrical stimulation to a patient's spinal cord using one or more electrode leads implantable in the patient's spinal column, each electrode lead comprising a plurality of spinal electrode contacts, the method comprising:

using one or more of the spinal electrode contacts to provide a first electrical stimulation to the patient's spinal cord, wherein the first electrical stimulation is configured to evoke a first stimulation artifact but not to evoke a detectable neural response in the patient's spinal cord,

using a second one or more of the spinal electrode contacts to record a first signal comprising a first stimulation artifact component,

fitting the first signal to a mathematical model to yield a template signal, wherein the mathematical model comprises an exponential decay,

using one or more of the spinal electrode contacts to provide second electrical stimulation to the patient's spinal cord, wherein the second electrical stimulation is configured to evoke a second stimulation artifact and a neural response in the patient's spinal cord,

using a one or more of the spinal electrode contacts to record a second signal comprising a second stimulation artifact component and a neural response component, and

using the second signal and the template signal to determine a third signal, wherein the third signal comprises the neural response component and comprises a smaller stimulation artifact component than does the second signal,

determining one or more features of the third signal, and

using the one or more features of the third signal for closed loop feedback adjustment of therapeutic stimulation.

14 . The method of claim 13 , wherein using the second signal and the template to determine a third signal comprises scaling the template signal with respect to the second signal and subtracting the scaled template signal from the second signal to yield the third signal.

15 . The system of claim 13 , wherein the mathematical model comprises a term of the form

V

⁡

(

t

)

=

V

0

⁢

e

-

t

τ

,

where V(t) is voltage as a function of time t, V 0 is peak voltage, and τ is a decay time constant wherein the decay time constant t depends on the resistance R and capacitance C of tissue near the electrode contacts.

16 . The system of claim 13 , wherein the control circuitry is further configured to determine one or more features of the third signal and to use the one or more features for closed loop feedback adjustment of therapeutic stimulation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: HADDOCK, ANDREW; AVVARU, SANDEEP
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 064710/0252 →
Continuity (2)
Provisional Application 63374011 · Aug 31, 2022
Related Publication 20240066298A1 · Feb 29, 2024
References Cited (35)
US 6181969B1 · Gord · 2001 [cited by applicant]
US 8606362B2 · He et al. · 2013 [cited by applicant]
US 8620436B2 · Parramon et al. · 2013 [cited by applicant]
US 9044155B2 · Strahl · 2015 [cited by applicant]
US 9259574B2 · Aghassian et al. · 2016 [cited by applicant]
US 9533148B2 · Carcieri · 2017 [cited by applicant]
US 10716937B2 · Feldman et al. · 2020 [cited by applicant]
US 10792491B2 · Feldman et al. · 2020 [cited by applicant]
US 10842996B2 · Baru et al. · 2020 [cited by applicant]
US 10881859B2 · Brill et al. · 2021 [cited by applicant]
US 10912942B2 · Weerakoon et al. · 2021 [cited by applicant]
US 10940316B2 · Hincapie Ordonez et al. · 2021 [cited by applicant]
US 11040192B2 · Weerakoon et al. · 2021 [cited by applicant]
US 11040202B2 · Marnfeldt · 2021 [cited by applicant]
US 11241580B2 · Esteller et al. · 2022 [cited by applicant]
US 20120092031A1 · Shi et al. · 2012 [cited by applicant]
US 20120095519A1 · Parramon et al. · 2012 [cited by applicant]
US 20120095529A1 · Parramon et al. · 2012 [cited by applicant]
US 20130289665A1 · Marnfeldt et al. · 2013 [cited by applicant]
US 20150080982A1 · Funderburk · 2015 [cited by applicant]
US 20150157861A1 · Aghassian · 2015 [cited by applicant]
US 20150231402A1 · Aghassian · 2015 [cited by applicant]
US 20150360038A1 · Zottola et al. · 2015 [cited by applicant]
US 20170296823A1 · Hershey et al. · 2017 [cited by applicant]
US 20180071520A1 · Weerakoon et al. · 2018 [cited by applicant]
US 20190366094A1 · Esteller · 2019 [cited by examiner]
US 20210252289A1 · Esteller · 2021 [cited by applicant]
US 20220062638A1 · Dinsmoor et al. · 2022 [cited by applicant]
US 20220184399A1 · Zhang et al. · 2022 [cited by applicant]
US 20220266027A1 · Zhang et al. · 2022 [cited by applicant]
US 20220296892A1 · Esteller et al. · 2022 [cited by applicant]
US 20230248977A1 · Esteller et al. · 2023 [cited by applicant]
Akhoun, Idrick, et al., “Electrically Evoked Compound Action Potential Artifact Rejection by Independent Component Analysis: Technique Validation,” Hearing Research, 302, 2013, pp. 60-73. [cited by applicant]
Miller, Charles A., et al., “Electrically Evoked Compound Action Potentials of Guinea Pig and Cat: Responses to Monopolar, Monophasic Stimulation,” Hearing Research, 119, 1998, pp. 142-154. [cited by applicant]
International Search Report and Written Opinion regarding corresponding PCT Application No. PCT/US2023/072941, mailed Nov. 17, 2023. [cited by applicant]